| | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2025 ( Subtotal = -$223 ) |
| 2025 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 2 | 5/8/2025 | NON-COMPETING CONTINUATION | -$223 |
|
 | Issue Date FY: 2024 ( Subtotal = $204,543 ) |
| 2024 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 2 | 2/2/2024 | NON-COMPETING CONTINUATION | $184,089 |
| 2024 | 2024 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 001 | 2 | 5/22/2024 | NON-COMPETING CONTINUATION | $20,454 |
|
 | Issue Date FY: 2023 ( Subtotal = $248,993 ) |
| 2023 | 2023 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Allergy and Infectious Diseases Research | 000 | 1 | 2/10/2023 | NEW | $248,993 |
|
|